Is BVS or SLBT more profitable?

BVS runs the higher net margin — BVS at 9.36% versus SLBT at -173.85%.

Bioventus Inc. (BVS) vs SL Science Holding Ltd (SLBT)

A side-by-side comparison of Bioventus Inc. and SL Science Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BVS

Bioventus Inc.

$887M

$13.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SLBT

SL Science Holding Ltd

$852M

$1.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BVS vs SLBT

growth of $100 · dividends reinvested · last 1y

BVS +27.8% (+27.8%/yr)SLBT -79.6% (-79.6%/yr)BVS compounded faster over this window

Log scale — wide-divergence pair

BVS SLBT

BVS vs SLBT: by the numbers

•BVS is the larger company ($887M vs $852M market cap).
•BVS is profitable (9.36% net margin) while SLBT runs a net loss (-173.85%).

Metrics side by side

Valuation

Metric	BVS	SLBT
P/E ratio	17.01	N/A
Forward P/E	16.82	N/A
P/S ratio	1.53	N/A
P/B ratio	3.89	373.20
EV / EBITDA	10.48	N/A
FCF yield	10.62%	N/A

Profitability

Metric	BVS	SLBT
Gross margin	68.00%	35.27%
Operating margin	10.63%	-174.65%
Net margin	9.36%	-173.85%
ROE	23.86%	-167.25%
ROIC	11.37%	-163.39%

Growth (annualized)

Metric	BVS	SLBT
Revenue CAGR (5Y)	11.82%	N/A
EPS CAGR (5Y)	-5.03%	N/A
FCF CAGR (5Y)	43.36%	N/A
Total return CAGR (5Y)	-0.81%	N/A

Frequently asked

Is BVS or SLBT more profitable?: BVS runs the higher net margin — BVS at 9.36% versus SLBT at -173.85%.

Go deeper

Full BVS analysis Full SLBT analysis Interactive comparison tool

Dig into the metrics

Bioventus P/E ratio Bioventus ROE SL Science ROE Bioventus operating margin SL Science operating margin Bioventus revenue growth SL Science revenue growth Bioventus free cash flow SL Science free cash flow

Bioventus & SL Science appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.